Searchable abstracts of presentations at key conferences in endocrinology

ea0016p672 | Steroid receptors | ECE2008

The vitamin D receptor agonist elocalcitol up-regulates L-type Ca2+ channel activity in human and rat bladder

Morelli Annamaria , Squecco Roberta , Francini Fabio , Failli Paola , Filippi Sandra , Chavalmane Aravinda , Fibbi Benedetta , Mancina Rosa , Vignozzi Linda , Silvestrini Enrico , Gacci Mauro , Colli Enrico , Adorini Luciano , Maggi Mario

Human bladder contraction mainly depends on Ca2+ influx, via L-type voltage-gated Ca2+ channels, and on RhoA/Rho-kinase contractile signalling, a pathway up-regulated in overactive bladder (OAB) syndrome. Elocalcitol (Elo) is a vitamin D receptor agonist inhibiting RhoA/Rho-kinase signalling in rat and human bladder, shown to ameliorate OAB symptoms in a clinical study. Since in normal bladder from Sprague–Dawley (SD) rats Elo treatment delayed the c...

ea0021p204 | Endocrine tumours and neoplasia | SFEBES2009

Temozolomide-induced regression of hepatic metastases in a pituitary corticotroph carcinoma with low O6-methylguanine-DNA methyltransferase expression

Burton Hannah , Annamalai Anand K , Dean Andrew , Kovacs Kalman , Antoun Nagui , Kirollos Ramez W , Simpson Helen L , Jeffries Sarah J , Burnet Neil G , Gurnell Mark

Background: Pituitary carcinoma occurs in ~0.2% of resected pituitary tumours, and carries a poor prognosis (mean survival <4 years), with standard chemotherapeutic regimens showing limited efficacy. However, recent evidence suggests that temozolomide, an orally active alkylating agent used principally in the management of glioblastoma, may also be effective in controlling aggressive/invasive pituitary adenomas/carcinomas. Low levels of expression of the DNA-repair enzyme ...

ea0044p232 | Reproduction | SFEBES2016

Levels of reactive oxygen species (ROS) in the seminal plasma predicts the effectiveness of L-carnitine to improve sperm function in men with infertility

Vessey Wayne , McDonald Cassandra , Virmani Ashraf , Almeida P. , Jayasena Channa , Ramsay Jonathan

Background: Oxidative stress is implicated in the pathogenesis of primary male infertility. Some studies suggest that administration of the amino acid derivative anti-oxidant, L-carnitine, may improve sperm quality. No previous study has investigated whether the anti-oxidant effects of L-carnitine relate to changes in sperm quality in men with infertility.Aim: Investigate whether L-carnetine significantly improves sperm function, and whether baseline lev...

ea0014p70 | (1) | ECE2007

Effect of L- carnitine supplementation on glycemic profile in patients with type 2 diabetes mellitus

Sakerhosseini Rahebeh , Rahbar Alireza , Saadat Avid , Pordal Amir hamzeh , Taleban Feroug azam , Golestan Banefsheh

Background: It has been thought that L-carnitine is effective in improving insulin-mediated glucose disposal either in healthy subjects or in type 2 diabetic patients,and carnitine plays an important role in diabetes mellitus omplications (cardiovascular disease).Objective: We designed this study to investigate the effects of oral L-carnitin administration on fasting plasma glucose (FPG) and glycosylated hemoglob (HbA1c), in patients with diabetes mellit...

ea0003p22 | Clinical Case Reports | BES2002

Prolactin elevation to 16,630 mU/l in a case of a large non-functioning pituitary adenoma

Syed A , Mathias D , Wahid S , Hall K , Weaver J

An 18-year old male presented with galactorrhoaea and obesity. PRL measured 16,630 mU/l, FSH 6.0 U/l, LH 5.0 U/l, testosterone 8.6 nmol/l, SHBG 15.0 nmol/l, IGF-1 22.0 nmol/l and TSH 1.39 mU/l. Several 24-hour urinary free cortisol estimations excluded hypercortisolism. Short synacthen test confirmed an intact HPA axis. Visual fields were full. Pituitary-MRI revealed a large adenoma extending into the right cavernous sinus without suprasellar extension. PRL started declining u...

ea0086p62 | Metabolism, Obesity and Diabetes | SFEBES2022

Effects of ethanolic extract of Allium Sativum L on the hippocampus of male Wistar rats with Streptozotocin (STZ)- induced brain insulin resistance

Afees Olanrewaju John , Roland Bejide Ayodele , Njideaka-Kevin Temitope , Priscilla Ajibade Testimony , Igbo Enya Joseph , Arietarhire Leviticus , Soremekun Oladimeji , Adeleke Stephen , Taiye Adelodun Stephen , Olatunji Sunday , Afolabi Toluwanimi , Zabdiel Abijo Ayodeji , Owolabi Joshua

Alzheimer’s disease (AD) development has a direct relationship with Brain-insulin resistance. Central in the pathology of AD are beta-amyloid and tau proteins associated with cognitive decline in the hippocampus. Allium sativum L. has been shown to have a neuroprotective effect. Thirty-two male Wistar rats (80-150 g) were assigned into A-D (n=8 each), and housed in standard plastic cages at 23&pm; 1°C. Group A received saline, groups B and C were ad...

ea0032p1021 | Thyroid (non-cancer) | ECE2013

Should subclinical hypothyroidism diagnosed during pregnancy be treated with long-term L-thyroxine?

Vaidya Bijay , Knight Bea , Hill Anita , Hattersley Andrew , Shields Beverley

Background: Subclinical hypothyroidism is common in pregnancy affecting about 5% of all pregnant women, and is associated with adverse pregnancy outcomes. There is a general consensus that subclinical hypothyroidism detected during pregnancy should be treated with L-thyroxine (Stagnaro-green et al. 2011, DeGroot et al. 2012). However, it is unclear whether the treatment should be limited only during the pregnancy or continued long-term. Therefo...

ea0028p43 | Clinical practice/governance and case reports | SFEBES2012

Disconnection hyperprolactinaemia in non-adenomatous sellar/parasellar lesions practically never exceeds 2000 mU/L

Korevaar Tim , Wass John , Grossman Ashley , Karavitaki Niki

Hyperprolactinaemia in association with a large sellar lesion could represent either tumoural secretion of prolactin (PRL) or stalk disruption by a non-prolactinoma: the differentiation has important therapeutic consequences. We have previously shown that based on currently used assays disconnection hyperprolactinaemia associated with non-functioning adenoma (NFA) practically never exceeds levels above 2000 mU/l. We aimed to verify our proposed disconnection hyperprolactinaemi...

ea0011p194 | Clinical practise and governance | ECE2006

Patients with serum prolactin >20,000 mU/l – review of presentation, management and outcome

Seevaratnam N , Khoo E , Rea R , Mansell P

Introduction: Large prolactinomas are uncommon and there is limited information on their presentation and progression. In this study we reviewed the presenting features, associated endocrinopathy and the response to treatment.Methods: 16 patients (aged 20–80 years, 75% male) were identified from our endocrine database as presenting with prolactin >20,000 mU/l between 1985 and 2005.Results: 75% of patients presented with ma...

ea0029p1579 | Thyroid (non-cancer) | ICEECE2012

Short-term combined treatment with L-thyroxine plus L-triiodothyronine in drops (LT4 plus LT3) in patients with persistent hypothyroidism and malabsorption during replacement therapy with L-T4.

Ippolito S. , Arpaia D. , Peirce C. , Lombardi G. , Biondi B.

The objective of our study was to evaluate the potential benefit of short-term combined treatment with LT4plusLT3 in patients with persistent hypothyroidism and malabsorption. We report ten cases of patients with hypothyroidism secondary to total thyroidectomy, in which high doses of L-T4 (2,7-3.5 mcg/kg/die) were not adequate to normalize thyroid function. TSH was persistently high (from 10 to 100 mU/L) with low serum levels of thyroid hormones.<p class="ab...